
Opinion|Videos|June 6, 2024
Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing Care
Author(s)Rocco Serrao, MD, FAAD
Rocco Serrao, MD, FAAD, addresses potential barriers to access and affordability of narrowband UVB phototherapy and topical medications for vitiligo treatment, while highlighting available resources to assist patients in overcoming these obstacles.
Advertisement
Episodes in this series

- How long would you treat this patient with this topical combination?
- How do you address any potential barriers to access or affordability associated with narrowband UVB phototherapy and topical medications, and what resources or support services are available to assist patients in overcoming these challenges?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus
2
Phase 2b Analysis Shows Consistent Vitiligo Repigmentation With Ritlecitinib
3
On the Horizon: Innovations in the Acne Treatment Pipeline
4
Dual ITK/JAK3 Inhibition Shows Strong Preclinical Activity in Severe Alopecia Areata
5











